Chimerigen

CD278 [ICOS] (human):Fc (mouse) (rec.)

CHF 430.00
In stock
CHI-HF-211ICOS-C100100 µgCHF 430.00
More Information
Product Details
Synonyms ICOS; Inducible T Cell Costimulator; CRP1; CD28-related Protein-1; AILIM
Product Type Protein
Properties
Source/Host CHO cells
Sequence

The extracellular domain of human CD278 [ICOS] (aa 21-139) is fused to the N-terminus of the Fc region of mouse IgG2a.

Crossreactivity Human
Biological Activity

Measured by its ability to inhibit human T cell proliferation induced by CD275 [B7-H2] (human):Fc (human) (rec.) (Prod. No. CHI-HF-210B7H2) in the presence of anti-CD3.

Purity ≥98% (SDS-PAGE)
Endotoxin Content <0.06EU/μg protein (LAL test; Lonza).
Reconstitution Reconstitute with 100 µl sterile water.
Add 1X PBS to the desired protein concentration.
Formulation Lyophilized from 0.2μm-filtered solution in PBS.
Protein Negative Control

Fc (mouse) IgG2a Control (rec.)

Other Product Data

NCBI reference NP_036224.1: CD278 [ICOS] (human)

Declaration Manufactured by Chimerigen.
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Centrifuge lyophilized vial before opening and reconstitution.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Working aliquots are stable for up to 3 months when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

CD278, also called inducible costimulator (ICOS) or CRP1 (CD28-related protein-1), is a member of the growing CD28 family of immune costimulatory receptors. Other family members are CD28, CTLA-4 and PD-1. ICOS is expressed on most CD45RO+ cells. ICOS expression is upregulated within approximately 24-48 hours of activation on Th primed cells. B7-H2, a member of the B7 family of costimulatory ligands, has been identified as the ICOS ligand. The B7-H2/ICOS interaction appears to play roles in T cell dependent B cell activation and Th differentiation.

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.